SSRI akathisia
Akathisia is restlessness caused by a medicine: an inner feeling of unease with an urge to keep moving that is hard to resist. People pace, shift their legs or cannot sit still, and it can feel very distressing. On an antidepressant it usually starts in the first weeks of treatment or after a dose increase. It can be mistaken for anxiety, and it has been linked with suicidal thoughts, so contact your prescriber promptly. If you have thoughts of harming yourself, call or text 988 in the US, or call 911 or 999 in an emergency.
Also called: Akathisia, Inner restlessness on antidepressants, Withdrawal akathisia.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What does akathisia feel like?
Sitting through a meal or a film becomes hard, and people rock, pace or keep crossing and uncrossing their legs. It can feel like anxiety, except that the pull to move is physical and sits in the legs. Many people find it distressing and hard to put into words. A 2024 study calls akathisia an underestimated but disturbing extrapyramidal side effect of antidepressants, which is the term for effects on the control of movement.
How often it happens on an antidepressant is not pinned down. The Lexapro and Zoloft labels list akathisia only among reports received after the medications went on sale, with no rate attached, and the Prozac label calls it an infrequent reaction in its trials. The 2024 study rated 198 people who had taken an SSRI or SNRI for four to eight weeks on the Barnes Akathisia Rating Scale and found akathisia in 25% of them. That is far above what the labels suggest, and it comes from one clinic sample using a rating scale, so treat it as a sign that mild cases get missed rather than as your odds.
The same study found akathisia more often in smokers and in younger patients. A 2009 review of SSRI-induced akathisia lists what else makes it more likely: a recent increase in the SSRI dose, more than one medicine that can cause akathisia, and akathisia before.
Is akathisia dangerous?
It asks for a prompt call rather than an emergency, and the reason is where it sits on the label. US prescribing information lists akathisia, along with agitation, irritability, hostility, aggressiveness, impulsivity, hypomania and mania, among symptoms reported in people taking antidepressants, and asks prescribers to consider changing the treatment when such symptoms are severe or start abruptly. The Prozac label also says that a causal link between these symptoms and either worsening depression or suicidal impulses has not been established, so finding akathisia on that list does not mean the rest is coming. The 2009 review calls akathisia important because it can be very bothersome and may lead to suicidal thoughts, which is why it is not something to sit on.
So restlessness strong enough that you cannot sit still is a reason to call your prescriber the same day rather than wait for your next appointment. The label asks families and caregivers to report changes like this to a health care provider immediately. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
Does akathisia ever go away?
It usually eases once the cause is dealt with, though stopping the drug does not always settle it on its own. A 2014 case report and review in Current Drug Safety describes a woman who developed severe akathisia after taking escitalopram for a few days, whose symptoms continued in spite of prompt discontinuation of the drug and then improved rapidly once her doctors treated the restlessness itself with propranolol and clonazepam. The authors write that early recognition, stopping the drug behind it and supportive treatment may relieve it rapidly. That is one case alongside a review of scattered reports, so the published data gives no timeline you can count on, which is the reason to make the call instead of waiting it out.
Can akathisia happen during withdrawal?
Restlessness is also reported when a dose comes down or stops, though the labels do not use the word akathisia there. The Lexapro label lists agitation, irritability, anxiety and dysphoric mood among symptoms after discontinuation, and the Zoloft label lists agitation too. Note whether your restlessness began after a reduction, because that changes what your prescriber will suggest.
How do you calm akathisia?
What helps depends on what is driving it, so this is a decision to make with your prescriber rather than alone. The questions worth asking: is this expected on the medicine and the dose I am on, how long might it last, and what should I do if it gets worse before my next appointment. Do not stop the antidepressant suddenly on your own, since an abrupt stop brings its own symptoms.
What to do
Call your prescriber the same day, and tell them when the restlessness started, which dose change came before it, and whether it followed a reduction rather than an increase. Ask someone close to you to stay with you while you wait if the restlessness is severe, and to tell you if they notice changes in how you act.
Check whether a symptom is common
How withClaro helps
- Log symptoms next to each dose change
- Share a dated report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- Akgoz I, Kara H, Ozcelik O, Donmez L, Eryilmaz M, Ozbey G. Evaluation of akathisia in patients receiving selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors. Behavioural Pharmacology, 2024.
- Koliscak LP, Makela EH. Selective serotonin reuptake inhibitor-induced akathisia. Journal of the American Pharmacists Association, 2009.
- Basu B, Gangopadhyay T, Dutta N, Mandal B, De S, Mondal S. A case of akathisia induced by escitalopram: case report & review of literature. Current Drug Safety, 2014.
All glossary terms